Olema (NASDAQ: OLMA) director receives grant of 29,500 stock options at $9.51
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Olema Pharmaceuticals director Harmon Cyrus received a grant of stock options covering 29,500 shares of common stock. The options have an exercise price of $9.51 per share and expire on June 18, 2036. Following this grant, Cyrus holds 29,500 stock options directly.
The options vest in 12 equal monthly installments starting June 18, 2026, conditioned on continued service. Any unvested portion will fully vest on the date of Olema’s next annual meeting of stockholders if not already fully vested, also subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Harmon Cyrus
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 29,500 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 29,500 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 29,500 options
Exercise price: $9.51 per share
Expiration date: June 18, 2036
+3 more
6 metrics
Options granted
29,500 options
Stock Option (Right to Buy) granted to director Harmon Cyrus
Exercise price
$9.51 per share
Conversion or exercise price of stock options
Expiration date
June 18, 2036
Option expiration for director grant
Underlying shares
29,500 shares
Common stock underlying the granted options
Vesting schedule
12 monthly installments
Equal monthly vesting starting June 18, 2026, subject to service
Position after grant
29,500 options
Total derivative holdings following this transaction
Key Terms
Stock Option (Right to Buy), Common Stock, exercise price, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: "9.5100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to the option vest in a series of 12 successive equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
annual meeting of stockholders financial
"Such shares vest in full on the date of the Issuer's next annual meeting of stockholders"
FAQ
What did Olema Pharmaceuticals (OLMA) director Harmon Cyrus report on this Form 4?
Director Harmon Cyrus reported receiving a grant of stock options for 29,500 shares of Olema Pharmaceuticals common stock. These options are compensation-related, not an open-market trade, and give the right to buy shares at a fixed exercise price of $9.51.
How many Olema Pharmaceuticals (OLMA) options did Harmon Cyrus acquire and at what price?
Harmon Cyrus acquired stock options for 29,500 underlying shares of Olema Pharmaceuticals common stock. The options carry an exercise price of $9.51 per share, meaning he can buy shares at that price if and when the options vest and are exercised.
What is the vesting schedule of Harmon Cyrus’s Olema Pharmaceuticals (OLMA) stock options?
The 29,500 stock options vest in 12 equal monthly installments starting June 18, 2026, subject to Cyrus’s continuous service. Any remaining unvested options will fully vest on the date of Olema’s next annual meeting if not already vested, also requiring continued service.
When do Harmon Cyrus’s Olema Pharmaceuticals (OLMA) options expire?
The stock options granted to Harmon Cyrus expire on June 18, 2036. If the options are not exercised by that expiration date, they lapse. The right to exercise them also depends on the options vesting under the stated service-based schedule.